革新的がん研究支援室

AMED news

AMED news - Detail

2018.12.26
Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells
A press release from the Japan Agency for Medical Research and Development (AMED):

Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells

Visit AMED website